TTR and amyloidosis: Current international guidelines recommend diagnostic work-up for CA in patients with increased cardiac wall thickness and red flags for CA.1 Pre-symptomatic screening should be offered to first-degree relatives of patients with variant transthyretin amyloidosis, and active monitoring is important to detect early markers of disease penetrance in carriers of TTR variants.